Pericytes: The lung-forgotten cell type
Open Access
- 23 March 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
Abstract
Pericytes are a heterogeneous population of mesenchymal cells located on the abluminal surface of microvessels, where they provide structural and biochemical support. Pericytes have been implicated in numerous lung diseases due including pulmonary arterial hypertension (PAH) and allergic asthma due to their ability to differentiate into scar-forming myofibroblasts, leading to collagen deposition and matrix remodelling and thus driving tissue fibrosis. Pericyte-extracellular matrix interactions as well as other biochemical cues play crucial roles in these processes. As an important functional component of the pulmonary vasculature, pericytes are involved in a number of chronic lung diseases. In this review, we give an overview of lung pericytes, the key pro-fibrotic mediators they interact with, and detail recent advances in preclinical studies on how pericytes are disrupted and contribute to lung diseases including pulmonary arterial hypertension (PAH), allergic asthma, and chronic obstructive pulmonary disease (COPD).Several recent studies using mouse models of PAH have demonstrated that pericytes contribute to these pathological events; efforts are currently underway to mitigate pericyte dysfunction in PAH by targeting the TGF-β, CXCR7, and CXCR4 signalling pathways. In allergic asthma, the dissociation of pericytes from the endothelium of blood vessels and their migration towards inflamed areas of the airway contribute to the characteristic airway remodelling observed in allergic asthma. Although several factors have been suggested to influence this migration such as TGF-β, IL-4, IL-13, and periostin, recent evidence points to the CXCL12/CXCR4 pathway as a potential therapeutic target. Pericytes might also play an essential role in lung dysfunction in response to ageing, as they are responsive to environmental risk factors such as cigarette smoke and air pollutants, which are the main drivers of COPD. However, there is currently no direct evidence delineating the contribution of pericytes to COPD pathology. Although there is a lack of human clinical data, the recent available evidence derived from in vitro and animal-based models shows that pericytes play important roles in the initiation and maintenance of chronic lung diseases and are amenable to pharmacological interventions. Therefore, further studies in this field are required to elucidate if targeting pericytes can treat lung diseases.Keywords
Funding Information
- Medical Research Council
- Longfonds
- Biotechnology and Biological Sciences Research Council
This publication has 182 references indexed in Scilit:
- Serotonylated fibronectin is elevated in pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defectBone, 2012
- Identification of a novel cell binding site of periostin involved in tumour growthEuropean Journal of Cancer, 2011
- Pericyte Requirement for Anti-Leak Action of Angiopoietin-1 and Vascular Remodeling in Sustained InflammationThe American Journal of Pathology, 2011
- Reversible or Irreversible Remodeling in Pulmonary Arterial HypertensionAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- The many paths to asthma: phenotype shaped by innate and adaptive immunityNature Immunology, 2010
- VEGFR1–mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathyProceedings of the National Academy of Sciences of the United States of America, 2009
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Profiling serum biomarkers in patients with COPD: associations with clinical parametersThorax, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006